<DOC>
	<DOCNO>NCT02669524</DOCNO>
	<brief_summary>In patient type 2 diabetes , incretin effect markedly reduce contribute relative insulin deficiency characterize patient . This defect believe due decreased effect GLP-1 almost cease effect GIP . Nevertheless , impact defect glucose tolerance fully understood . The so-called gastrointestinal-mediated glucose disposal ( GIGD ) measure glucose handling , include incretin effect , also factor affect glucose disposal ( e.g . glucagon secretion ) . Interestingly , patient type 2 diabetes exhibit elevate plasma glucagon level fast state , glucagon concentration fail decrease appropriately may even increase response ingestion glucose show exaggerated increase mixed meal . With current project investigator wish elucidate paradoxical glucagon response observe patient type 2 diabetes affect GIGD , incretin effect postprandial glucose excursion . Ten patient type 2 diabetes 10 healthy match control subject enrol randomised , placebo-controlled , double-blinded study . The aim examine effect glucagon receptor antagonist ( GRA ) gastrointestinal-mediated glucose disposal ( GIGD ) , incretin effect postprandial glucose excursion patient type 2 diabetes healthy control . Participants attend two oral glucose tolerance test ( OGTT ) , two isoglycaemic iv glucose infusion ( IIGI ) two standardise liquid meal .</brief_summary>
	<brief_title>Dissection Gastrointestinal-mediated Glucose Disposal Incretin Defect Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>Patients type 2 diabetes Caucasians 35 year age diet metformin treat type 2 diabetes least 3 month ( diagnose accord criterion World Health Organization ( WHO ) Normal haemoglobin Informed consent Healthy subject Normal fast plasma glucose ( FPG ) &lt; 6.1 mmol/l HbA1c &lt; 42 mmol/mol ( 6.0 % ) Normal haemoglobin Age 35 year Informed consent Patients type 2 diabetes Inflammatory bowel disease Intestinal resection Nephropathy ( serum creatinine normal range and/or albuminuria ) Liver disease ( serum alanine aminotransferase ( ALAT ) and/or serum aspartate aminotransferase ( ASAT ) &gt; 2Ã—normal value ) Treatment medicine pause 12 hour Pregnancy and/or breastfeed Family history pancreatic islet tumour Age 80 year Healthy subject Diabetes prediabetes reduce glucose tolerance : FPG &gt; 6.0 mmol/l and/or HbA1c &gt; 42 mmol/mol First degree relatives type 2 diabetes Inflammatory bowel disease Intestinal resection Treatment medicine pause 12 hour Pregnancy and/or breastfeed Age 80 year</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>